Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

P.S. There is ZERO mention of Algernon's FAIMS POC RUO Device requiring, Field Testing, Callaboration and consensus building between Cannabix, regulators, and industry scientist as stated per Cannabix technologies Inc - not to mention court certification, and "what's actually marijuana impairment" question.

Currently the BCU will collect key real-time parameters of breath flow rate, total volume, relative humidity measurements, as well as carbon dioxide levels, and temperature – these measurements and others, will help Cannabix, regulators and industry scientists determine key physiologic parameters needed for standardizing a breath sample for FAIMS THC content and its decay metrics.

Therefore, the path to commercialization between Algernon and Cannabix are not the same. Why would or should they be? Their two different companies that happen to share the same technology. Something we have all known since 2015 (Pre- Btec IPO). How one cannot see Cannabix simply has more complex hurdles to jump over (in real time) is not being honest. Trying to smear Algernon's path(s) to profits does not change facts. So what's the big deal? It's not like Cannabix shareholders haven't had dozens of opportunities to cash in on it's yoyo price action over the years, and ample opportunity to buy into Algernon at rock bottom prices to this day and years over. The whining should stop immediately and do some gut check due dilligence.

/////AMG